Insider Trading Research -- Alerts for Ariad Pharmaceuticals, Cell Therapeutics, Staples, Sirius XM, Facebook, and Bank of America
PHOENIX, March 25, 2014 /PRNewswire/ -- Today, Insiderslab.com released the latest insider trading research for Ariad Pharmaceuticals (NASDAQ: ARIA), Cell Therapeutics (NASDAQ: CTIC), Staples (NASDAQ: SPLS), Sirius XM (NASDAQ: SIRI), Facebook (NASDAQ: FB), and Bank of America (NYSE: BAC). US stock investors can access these reports through the links below, including stock performance, insider trading signals, and visual results.
(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)
Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA): By the end of last trading session, the shares of Ariad Pharmaceuticals (NASDAQ: ARIA) lost 3.06% (or US$0.24) to US$7.60 with 13.08 million shares exchanged hands, compared to daily average volume of 15.80 million. Compare to the industry of Biotechnology dropped 0.57%, its competitor Pfizer Inc. (PFE) slid 2.14% to US$31.49. Insiderslab.com found company insiders sold their shares at the price of US$7.89 on March 21, including company President and CSO, Timothy P. Clackson. Investors may want to find out how Ariad Pharmaceuticals insiders like CEOs, CFOs and Directors are thinking about the future of the company. Check this insider trade report for ARIA here.
Exclusive Report: http://www.insiderslab.com/PR3/032514A/ARIA/AriadPharmaceuticals
Cell Therapeutics Inc (NASDAQ: CTIC): Within the last trading session, the Cell Therapeutics (NASDAQ: CTIC) shares finally plunged 6.30% to US$3.57 with about 12.95 million shares exchanged hands for the session, compared to its average volume of 5.23 million shares. While the sector of Healthcare lost 0.88%, its rival Baxter International Inc. (BAX) slid 1.26% to US$66.86. Insiderslab.com found company President and CEO, James A. Bianco, sold his shares at the price of US$3.79 on March 21. Investors may want to find out how Cell Therapeutics insiders like CEOs, CFOs and Directors are thinking about the future of the company.
Exclusive Report: http://www.insiderslab.com/PR3/032514A/CTIC/CellTherapeutics
Staples, Inc. (NASDAQ: SPLS): During the last trading session, the Staples (NASDAQ: SPLS) shares earned 1.66% to US$11.64 with about 14.26 million shares exchanged hands for the session, compared to its average volume of 12.01 million shares. The Specialty Retail Industry lost 0.79%. Its competitor Office Depot, Inc. (ODP) dropped 4.12% to US$4.19. Insiderslab.com found company President, Shira Goodman, purchased her shares at the price of US$11.44 on March 20. Insiderslab.com believes that it is a clever way to check if insiders like CEOs, CFOs, and Directors in Staples are starting to sell more company shares. See insider trade report for SPLS here.
Exclusive Report: http://www.insiderslab.com/PR3/032514A/SPLS/Staples
Today Insiderslab.com also observed abnormal trade volume for the following companies; insiders may involve trading in these companies. It will take some time for insiders to report their trades. Read these reports and add these companies into your Insider Trade Radar.
Sirius XM Holdings Inc (NASDAQ: SIRI):
Exclusive Report: http://www.insiderslab.com/PR3/032514A/SIRI/SiriusXM
Facebook Inc (NASDAQ: FB):
Exclusive Report: http://www.insiderslab.com/PR3/032514A/FB/Facebook
Bank of America Corp (NYSE: BAC):
Exclusive Report: http://www.insiderslab.com/PR3/032514A/BAC/BankofAmerica
Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.
Insiderslab.com covers insider trade data in major stock markets in the U.S., Hong Kong, Mainland China, and Singapore. Insiderslab.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.
Please visit insiderslab.com/disclaimers/disclaimers.php for details.
SOURCE Insiderslab.com; Insiders.hk